Establishment Labs Holdings Inc. - Common Shares (NQ:ESTA)

Establishment Labs (NASDAQ:ESTA) reported third-quarter revenue growth of 33.9% year over year to $72 million, driven by U.S. market-share gains and expansion across international markets, while the...

What Establishment Labs (ESTA) Said on Its Q3 Earnings Call ↗

October 29, 2026

Via MarketBeat

Performance

52-Week Range 36.3% below 52-week high

62.15

47.0052W Low 97.5952W High

1 Week 13.5% below 1-week high

60.251W Low 71.881W High

Establishment Labs Holdings Inc. - Common Shares (ESTA) traded between $47.00 and $97.59 over the past 52 weeks and last traded at $62.15, 36.3% below its 52-week high. Over the past week it ranged between $60.25 and $71.88.

Past 12 Months

-7.2%

-6.5%

-33.0%

-11.5%

-9.7%

+30.0%

1W -$4.80

1M -$4.32

3M -$30.65

6M -$8.09

YTD -$6.70

1Y +$14.35

ESTA was +30.0% over the past year, -11.5% over six months, -9.7% year to date, -7.2% in the last week.

12 Months vs Market

ESTA

+30.0%

DIA

+9.2%

SPY

+10.5%

QQQ

+8.7%

IWM

+14.5%

Over the past 12 months ESTA returned +30.0% versus DIA (Dow) +9.2%, SPY (S&P 500) +10.5%, QQQ (Nasdaq 100) +8.7% and IWM (Russell 2000) +14.5%.

Volume & Liquidity 0.41× 3-mo avg

Today 191,540 3-mo avg 463.4K

813.1K

529.3K

463.4K

535.3K

YTD

520.3K

526.3K

ESTA most recently traded 191,540 shares against a 3-month average daily volume of 463.4K.

More News

Establishment Labs® Reports Third Quarter 2026 Financial Results

October 29, 2026

Establishment Labs® to Announce Third Quarter 2026 Financial Results on October 29

October 19, 2026

Establishment Labs Holdings (NASDAQ:ESTA) Meets Minervini Trend Template and High Growth Momentum Criteria ↗

July 07, 2026

Via Chartmill

Establishment Labs® Receives FDA Approval for Additional Sizes of Motiva Implants®

October 05, 2026

Establishment Labs® Highlights New Breast Tissue Preservation Data and Announces Minimally Invasive Product Extensions at the 11th World Symposium on Ergonomic Implants

September 21, 2026

The GLP-1 Boom Created a Tissue Gap Fillers Were Not Built For

August 12, 2026

From USA News Group

Establishment Labs Q2 Earnings Call Highlights ↗

August 06, 2026

Via MarketBeat

Establishment Labs® Reports Second Quarter 2026 Financial Results

August 06, 2026

Jim Cramer: Bending Spoons Is A ‘Really Good’ Software Company, Recommends Buying This Industrial Stock ↗

July 31, 2026

Via Benzinga

Establishment Labs® to Announce Second Quarter 2026 Financial Results on August 6

July 23, 2026

A Hedge Fund Dumped Establishment Labs Shares Worth $6.6 Million. Here's a Closer Look at the Transaction. ↗

July 05, 2026

A Nasdaq-Listed Regenerative Tissue Company Just Opened a Lab: The Next Step in Scaling a Platform Built for a NEW Aesthetics Opportunity

July 01, 2026

From Biotech Insider

Establishment Labs® Appoints Taylor Harris to Board of Directors

June 29, 2026

The Aesthetics Giants Just Confirmed “Ozempic Face” Is Real — and a Newly Public Regenerative Player Wants to Compete for It

June 25, 2026

From Biotech Insider

Establishment Labs® Added to Membership of U.S. Small-Cap Russell 2000® Index

June 25, 2026

Wealth Manager Sells $7 Million of Establishment Labs After Massive Gains. Is This Medical Device Stock a Buy? ↗

May 30, 2026

After Fifty Years of Implants, a Newly Public Biotech Is Trying to Rebuild the Breast Instead

May 27, 2026

From Biotech Insider

The Newest Name on Nasdaq Wants to Help the Body Rebuild Itself

May 22, 2026

From Energy Metal News

Route 92 Medical Announces Appointment of Raj Denhoy as Chief Financial Officer

May 18, 2026

From Route 92 Medical, Inc.

Core Natural Resources Stock Trails the Market, but One Fund Is Buying Up Shares ↗

May 14, 2026

What to Know About This Fund’s $23 Million Appian Buy Amid AI Automation Growth and a 40% Stock Drop ↗

May 14, 2026

Warrior Met Coal Stock Has Soared 80%. One Investor Just Trimmed $32 Million ↗

May 14, 2026

ESTA Founder Sells $7.9M on Earnings Day — Here's Why that's Not the Story ↗

May 11, 2026